Exit

Save the date for the Turkish Pharmaceutical Forum

BMI SYSTEM will attend the Turkish Pharmaceutical Forum taking place in Istanbul on November 3-4, 2015. Why should you attend this event? •  To hear from CEOs of leading Turkish and MENA pharma companies •  To find out how to advance your business model in a strongly regulated environment •  To discover business cases from […]

Read more

Innovation & Transparency in Compliance: BMI SYSTEM’s latest event

organize a breakfast seminar on: Thursday 12th November 2015 From 09:00am to 11:00am Regulatory approach Review of latest developments on the ABPI and EFPIA requirements Impact of transparency regulations on corporate responsibilities Reflection on 2015 – International organisations vs local requirement and application Case study Testimony of Ian Cornish, IS Business Partner, Sanofi UK & […]

Read more

BMI SYSTEM at the 9th Annual Forum on Transparency and Aggregate Spend – Washington D.C.

BMI SYSTEM will attend the 9th Annual Forum on Transparency and Aggregate Spend in Washington D.C., from 17 to 19 August 2015, as main speaker and exhibitor. See full information on the CBI’s website dedicated to this event.

Read more

Beyond Transparency at the PharmaCompliance

On June 23rd, BMI SYSTEM participated as a Gold Sponsor in the PharmaCompliance 2015, which took place in Paris. The objective of this event was to discuss healthcare ethics and compliance, particularly the transparency of financial relationships between pharmaceutical companies and healthcare professionals and organisations, nationally and globally. It was also a good opportunity, through […]

Read more

BMI SYSTEM Event: Beyond Transparency

Read more

BMI SYSTEM Discusses EFPIA & ABPI Disclosure Requirements at Global Transparency Reporting Congress in London (15-16 April 2015)

BMI SYSTEM attended the Global Transparency Reporting Congress in London as a speaker and sponsor. A lot of issues around the first EFPIA disclosure of Transfer of values were discussed: • How to manage consent and data privacy • EFPIA requirements and local regulations • The impact of the disclosure on HCPs relationships with the […]

Read more

BMI SYSTEM in Turkey

BMI SYSTEM was in Istanbul, Turkey from March 2nd to 5th 2015. Laurent Clerc, BMI SYSTEM’s Regulatory Affairs Expert, met with several pharmaceutical companies established in Turkey as well as with the IEIS, the pharmaceutical manufacturers association of Turkey. The purpose was to introduce BMI SYSTEM’s solutions which enable to meet the EFPIA disclosure requirements […]

Read more

EFPIA roundtable shows transparency crucial despite potential hurdles

A roundtable, organised last month by Pharmadisclosure.eu, the multi-stakeholder initiative supported by the European Federation of Pharmaceutical Industries and Associations (EFPIA) has revealed how the pharmaceutical industry will be expected to adapt to a culture of transparency in line with changing societal expectations. The event, entitled “Going Live: Implementation of the Disclosure Code” took place […]

Read more

BMI SYSTEM, official sponsor of the Veeva European Commercial Summit

BMI SYSTEM participated as official partner, sponsor and speaker in the 2014 Veeva European Commercial Summit in Barcelona from 3 to 5 December. This event, organised by Veeva, a leading provider of products for customer relationship management and regulated content management, gathered more than 450 life sciences professionals. The purpose of this event was to […]

Read more
Transparency and Compliance in Turkey

BMI SYSTEM addressed EFPIA regulations in Turkey

Pharmaceutical companies worldwide face new rules on their transparency obligations in terms of their relations with HCPs and HCOs. In the EFPIA zone, which represents 33 European countries, pharmaceutical companies have to publicly disclose the monetary value of any financial sponsorship and other significant indirect support provided to healthcare professionals and organisations from 2016. This means […]

Read more
Close
Go top